Serbia - Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale
Since 2014, Serbia Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale increased 9.5% year on year. At €8,980,270 in 2019, the country was number 13 among other countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. Serbia is overtaken by Portugal, which was ranked number 12 with €11,560,430.66 and is followed by Romania with €5,528,322. Denmark topped the ranking with €3,801,340,964.3 in 2019, that is a fall of 2.9% compared to 2018. Belgium, Italy and Germany respectively ranked number 2, 3 and 4 in this ranking. Italy recorded the best 5 years average growth at +51.7% per year, while Netherlands was the worst growing country at -13.4% per year.
Loading...
Date | Euros |
---|---|
2019 | 8,980,270.00 |
2018 | 8,349,541.00 |
2017 | 8,261,570.00 |
2016 | 7,840,344.00 |
2015 | 5,299,285.00 |
How does Serbia rank in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?
# | 16 Countries | Euros | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Denmark
|
3,801,340,964.30 | 2019 | -2.9 % | +26.5 % | View data | |
2 |
#2
Belgium
|
1,624,727,500.00 | 2018 | +46.2 % | NA | View data | |
12 |
#12
Portugal
|
11,560,430.66 | 2019 | +8.3 % | +15.4 % | View data | |
13 |
#13
Serbia
|
8,980,270.00 | 2019 | +7.5 % | +9.5 % | View data | |
14 |
#14
Romania
|
5,528,322.00 | 2018 | -3.0 % | NA | View data |